Form 13-F position report

ORAMED PHARM INC

Reported by SG Americas Securities LLC

ORMP CUSIP 68403P203 Manager CIK 0001313360

Reported 8,631 shares, down 4,910 (36.3%) from the prior quarter.

Reported value -58.7%; share count -36.3% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q4 2021
Shares 8,631 Quarter-end amount reported
Reported value $123,000 Fair value at quarter end
Consecutive quarters held 2 Through Q4 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 298000
2021-12-31 123000
2022-03-31 0
2022-06-30 213000
2022-09-30 67000
2022-12-31 125000
2023-03-31 0
2025-03-31 50000
2025-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

9 quarters
Quarterly reported position history for ORAMED PHARM INC held by SG Americas Securities LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2025 Reduced 0 -23,446 (-100.0%) 0 $0 2025-08-08
Q1 2025 New 23,446 +23,446 (0.0%) < 0.01% $50,000 2025-04-15
Q1 2023 Reduced 0 -10,370 (-100.0%) 0 $0 2023-04-28
Q4 2022 Unchanged 10,370 0 (0.0%) < 0.01% $125,000 2023-02-02
Q3 2022 Reduced 10,370 -36,162 (-77.7%) < 0.01% $67,000 2022-10-31
Q2 2022 New 46,532 +46,532 (0.0%) < 0.01% $213,000 2022-07-29
Q1 2022 Reduced 0 -8,631 (-100.0%) 0 $0 2022-04-29
Q4 2021 Reduced 8,631 -4,910 (-36.3%) < 0.01% $123,000 2022-02-07
Q3 2021 New 13,541 +13,541 (0.0%) < 0.01% $298,000 2021-11-01

Who else reported the position

124 managers reported ORAMED PHARM INC for Q4 2021.

Managers reporting ORAMED PHARM INC in Q4 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 1,558,607 +125,059 < 0.01% $22,257,000 15 qtrs
MILLENNIUM MANAGEMENT LLC Added 761,570 +692,384 < 0.01% $10,875,000 10 qtrs
CITADEL ADVISORS LLC Added 534,225 +515,329 < 0.01% $7,629,000 6 qtrs
STATE STREET CORPORATION Added 512,246 +24,247 < 0.01% $7,315,000 3 qtrs
TWO SIGMA INVESTMENTS LP New 402,097 +402,097 0.01% $5,742,000 1 qtr
MORGAN STANLEY Added 386,437 +266,432 < 0.01% $5,518,000 33 qtrs
VANGUARD GROUP INC Added 285,162 +125,467 < 0.01% $4,072,000 3 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 245,345 -1,626 < 0.01% $3,503,000 11 qtrs
NORTHERN TRUST CORPORATION Added 243,125 +17,294 < 0.01% $3,472,000 3 qtrs
TWO SIGMA ADVISERS LP New 227,300 +227,300 < 0.01% $3,246,000 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2021
Filed
February 07, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
8,631
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.